Yu J - Search Results

1

Detection of novel germline mutations in six breast cancer predisposition genes by targeted next-generation sequencing.

Dong L, Wu N, Wang S, Cheng Y, Han L, Zhao J, Long X, Mu K, Li M, Wei L, Wang W, Zhang W, Cao Y, Liu J, Yu J, Hao X. Dong L, et al. Among authors: yu j. Hum Mutat. 2018 Oct;39(10):1442-1455. doi: 10.1002/humu.23597. Epub 2018 Aug 2. Hum Mutat. 2018. PMID: 30039884

2

Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients.

Ren X, Yu J, Liu H, Zhang P, An X, Zhang N, Hao X. Ren X, et al. Among authors: yu j. Cancer Biother Radiopharm. 2006 Feb;21(1):22-33. doi: 10.1089/cbr.2006.21.22. Cancer Biother Radiopharm. 2006. PMID: 16480328 Clinical Trial.

3

Th1 polarization and apoptosis-inducing activity of CD4+ T -cells in cytokine-induced killers might favor the antitumor cytotoxicity of cytokine-induced killers in vivo.

Yu J, Ren X, Cao S, Zhang W, Hao X. Yu J, et al. Cancer Biother Radiopharm. 2006 Jun;21(3):276-84. doi: 10.1089/cbr.2006.21.276. Cancer Biother Radiopharm. 2006. PMID: 16918305

4

Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment.

Ren XB, Yu JP, Cao S, Ren BZ, Li H, Liu H, Min WP, Hao XS. Ren XB, et al. Cancer Biother Radiopharm. 2007 Apr;22(2):223-34. doi: 10.1089/cbr.2007.334. Cancer Biother Radiopharm. 2007. PMID: 17600469 Clinical Trial.

5

IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Li R, Wei F, Yu J, Li H, Ren X, Hao X. Li R, et al. Among authors: yu j. Cancer Biol Ther. 2009 Jul;8(14):1402-8. doi: 10.4161/cbt.8.14.8882. Epub 2009 Jul 30. Cancer Biol Ther. 2009. PMID: 19597340 Free article.

6

Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells.

Yu J, Ren X, Yan F, Li H, Cao S, Chen Y, Sun H, An X, Zhang N, Hao X. Yu J, et al. Transpl Int. 2011 Feb;24(2):201-12. doi: 10.1111/j.1432-2277.2010.01185.x. Epub 2010 Nov 10. Transpl Int. 2011. PMID: 21062369 Free article.

7

Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors.

Yu J, Ren X, Li H, Cao S, Han Y, Enoki T, Kato I, Cao C, Hao X. Yu J, et al. Cancer Biother Radiopharm. 2011 Aug;26(4):485-94. doi: 10.1089/cbr.2010.0927. Epub 2011 Jul 28. Cancer Biother Radiopharm. 2011. PMID: 21797674 Clinical Trial.

8

[Expression of indoleamine 2, 3-dioxygenase and its correlation with prognosis in breast cancer patients].

Liu JT, Wei LJ, Yu JP, Li H, Li RM, Zang FL, Sun JY, Ren XB. Liu JT, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):513-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22093628 Chinese.

9

Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.

Yu J, Sun J, Wang SE, Li H, Cao S, Cong Y, Liu J, Ren X. Yu J, et al. Clin Dev Immunol. 2011;2011:469135. doi: 10.1155/2011/469135. Epub 2011 Oct 24. Clin Dev Immunol. 2011. PMID: 22110525 Free PMC article.

10

Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.

Liu L, Zhang W, Qi X, Li H, Yu J, Wei S, Hao X, Ren X. Liu L, et al. Among authors: yu j. Clin Cancer Res. 2012 Mar 15;18(6):1751-9. doi: 10.1158/1078-0432.CCR-11-2442. Epub 2012 Jan 24. Clin Cancer Res. 2012. PMID: 22275504 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,652 results

Search Page

Filters